-
Is Ventas's Astounding 320% 10-Year Shareholder Return Plausible Going Forward? Q3 Earnings & Future Focus
Monday, October 27, 2014 - 9:25am | 1020Read More...During the past decade or so, investors in this leading health care REIT have been rewarded with outsized gains. What do Q3 earnings and future plans tell investors moving forward? Past Performance The Ventas, Inc. (NYSE: VTR) website displays a calculated 10-year total shareholder return of...
-
Barron's Recap: The New American Express
Sunday, September 14, 2014 - 4:23pm | 896Read More...This weekend in Barron's online: how American Express is charging ahead and a look at the Senate race in Kentucky, as well as the prospects for Alibaba, Lam Research, Popular, Ventas, Provident Financial and more. Cover Story "The New American Express" by Avi Salzman. With...
-
Market Wrap For June 2: Dow, S&P Continue Rising, Nasdaq Slightly Lower
Monday, June 2, 2014 - 4:36pm | 2382Read More...U.S. stocks were mostly positive on the first trading session of June in which investors were left confused over ISM's May Manufacturing data which was revised twice. Both the S&P 500 and Dow Jones indices reached new highs. The S&P 500 index reached a new all time high of 1,925.88...
-
An Obamacare Boost For Health Care REITs?
Thursday, March 20, 2014 - 7:15am | 853Read More...What does Obamacare care mean for health care real estate investment trusts (REITS) such as HCP (NYSE: HCP), Health Care REIT (NYSE: HCN), Healthcare Trust of America (NYSE: HTA) and Ventas (NYSE: VTR)? Scott Peters, chief executive of Healthcare Trust of America, told MarketWatch this week that...
-
Annaly Capital, VIVUS And Others Insiders Have Been Buying
Friday, November 15, 2013 - 3:48pm | 813Read More...Insiders may sell shares for any number of reasons, but conventional wisdom says that insiders really only buy shares of a company for one reason -- they believe the stock price will rise and they want to profit from it. Pullbacks and sell-offs provide a perfect opportunity for investors who have...
-
Three More Defensive Stock Picks for 2013 (LLY, PFE, VTR)
Monday, December 10, 2012 - 4:12pm | 644Read More...Bank of America Merrill Lynch offered some defensive stock picks for 2013 in a research report. Two drug makers and an REIT focused on health care facilities made the list. They were Eli Lilly (NYSE: LLY), Pfizer (NYSE: PFE) and Ventas (NYSE: VTR). Here is a quick look at how these three picks...
-
Morgan Keegan Anticipates VTR Earnings
Monday, April 25, 2011 - 8:10am | 136Read More...Morgan Keegan's FFO/share estimate on Ventas, Inc. (NYSE: VTR) is $0.75, which is “in line with the First Call consensus.” “Our FAD/share estimate of $0.72 is in line with the SNL consensus,” Morgan Keegan writes. “Ventas has two large acquisitions pending – Atria Senior Living and Nationwide...
-
Morgan Keegan Analyzes Publicly Traded Healthcare REITs (HCP, HCN, VTR, NHP)
Wednesday, March 16, 2011 - 7:20am | 217Read More...In a report released this morning, Morgan Keegan provides an analysis of publicly traded healthcare REITs with respect to FFO/FAD, investment composition, and asset coverage ratios. “Since our last report, we have seen four noteworthy large deals: HCP, Inc.'s (NYSE: HCP) $6.1 billion acquisition of...
-
Morgan Keegan Raises PT on Ventas to $62 (VTR)
Friday, February 18, 2011 - 9:39am | 83Read More...Morgan Keegan is out with its report today on Ventas (NYSE: VTR), raising its PT from $60 to $62. In a note to clients, Morgan Keegan writes, "The company issued 2011 FFO guidance of $3.06-$3.14. We are raising our 2010 FFO estimate from $3.04 to $3.09 and our 2012 estimate from $3.15 to $3.21. We...
-
Goldman Sachs Initiates Coverage on Ventas (VTR)
Monday, November 29, 2010 - 12:09pm | 113Read More...Goldman Sachs initiates coverage on Ventas (NYSE: VTR) with a Neutral rating and a $53 price target. In a note to clients, Goldman Sachs writes, "We arrive at our price target by assuming a premium to our forward NAV estimate of $44, given VTR's premier asset quality, strong balance sheet, superior...
-
Goldman Sachs Initiates Coverage on Ventas At Neutral
Monday, November 29, 2010 - 7:50am | 22Read More...Goldman Sachs has initiated coverage on Ventas, Inc. (NYSE: VTR) with a Neutral rating.
-
Morgan Keegan Updates Ventas Model Following Acquisition
Monday, October 25, 2010 - 7:54am | 153Read More...Ventas, Inc. (NYSE: VTR) announced that it will purchase 118 senior living assets from Atria Senior Living Group. Ventas will pay $3.1 billion in stock, cash, and debt assumption/retirement, or $230,000 per unit, for the facilities, which it will operate via a taxable REIT subsidiary. “We have...
-
Ventas To Acquire Sunrise's Real Estate Interests
Tuesday, October 5, 2010 - 7:57am | 143Read More...Jefferies & Co. has published a research report for Ventas Inc. (NYSE: VTR) reporting that solid growth can be expected while being fueled by acquisitions. In the report, Jefferies writes "Transaction highlights: 1) VTR will acquire SRZ's interests in 58 senior living communities for total...
-
KeyBanc Capital Markets Downgrades Ventas (VTR) To Hold
Thursday, March 25, 2010 - 8:41am | 196Read More...KeyBanc Capital Markets analysts Karin A. Ford, Jordan Sadler and Austin Wurschmidt downgraded their rating of Ventas, Inc. (NYSE: VTR) from Buy to Hold and removed the $48 price target. The actions were taken by the analysts because once Ventas, Inc. reached the former price target, they felt that...
